Health & Medicine
FDA Advisory Panel Will Assess Avandia Safety in June
The Food and Drug Administration will hold a meeting in June to reassess the safety of GlaxoSmithKline's former blockbuster diabetes drug Avandia almost three years after they curbed its sales over cardiovascular risks.
Latest Research Articles
New HIV/AIDS Drug In South Africa Streamlines Treatment And Lowers Costs
FDA Warns Of Potentially Deadly Stimulant Found In Dietary Supplements
Weight-Loss Surgery May Alter Genes And Promote A Healthier Metabolism
People Ditching Tobacco For E-Cigs Don't Return To Tobacco But May End Up 'Smoking' More
Woman Indicted For Allegedly Feigning Cancer To Raise Money For Heroin
Lotus Births Used By Some Parents In Natural Birthing
UN Plan Hopes To Eliminate Childhood Deaths Caused By Pneumonia And Diarrhea By 2025
Exercising And Preparing Your Own Meals Not As Healthy As You Think
Kidney Disease More Likely To Occur In People Who Carry Weight In Their Waist
Southerners Aren't The Fattest, They Just Lie Less On Surveys, Study Shows
Researchers Explore Link between Apple-Shaped Bodies and Kidney Disease
Sounds can Help Strengthen Memory during Sleep
MOST POPULAR
-
Weak Spot in Earth's Magnetic Field Raises Concerns for Humanity's Future
-
Spectacular Northern Lights Show Possible in 10 States as Geomagnetic Storm Approaches
-
Earth's Magnetic North Pole Shifts Toward Russia, Scientists Update Its Location
-
Undersea Volcano Off Oregon Coast Could Erupt in 2025 After Scientists Notice 'Swelling'
-
Northern Lights Could Grace the US Skies Tonight – Here’s Where to Look
